Delivery Order SPE2DB22D2006-SPE2DB23FV9DB
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $5,016.28 for the procurement of Vigamox 0.5% eye drops. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. The contract is for the delivery of a wide...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,281.01 firm-fixed-price delivery order is for the supply of Vigamox 0.5% eye drops (3 mL) and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a broad range of...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of VIGAMOX 0.5% eye drops (3 ml) to support military healthcare programs. The contract, valued at $15,847.53, is a delivery order awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award, valued at $10,643.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product used in medical treatment. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $2,838.19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of Vigamox 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,850.50 firm-fixed price contract is for the supply of Vigamox 0.5% eye drops, a pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Vigamox 0.5% eye drops (3ml) to the Defense Logistics Agency (DLA). The $1,590.43 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Vigamox 0.5% eye drops with a ceiling value of $3,412.28. The contract is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency supporting military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. government has awarded a Delivery Order contract worth $2,754.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Vigamox 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- This federal contract award, valued at $1,778.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Vigamox 0.5% eye drops, a medical product used for various eye care needs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 21, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FV9DBDelivery Order
This federal contract award, valued at $1,074.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vigamox 0.5% eye drops (3mL) and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is likely one of the many delivery orders placed under the DLA IDC to fulfill the government's requirements for essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other healthcare-related items.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/17/23 |